Speciality: Nephrology
Description:
A warm welcome to all the medical professionals in this interesting session on Holistic CRM Care : Optimizing Kidney Protection with SLGT2-inhibitor
Holistic care in chronic kidney disease (CKD) management emphasizes kidney protection alongside overall patient well-being, with SGLT2 inhibitors playing a pivotal role. These drugs not only slow CKD progression but also address comorbidities like heart failure and diabetes, reducing hospitalization risks and enhancing quality of life. Their ability to lower albuminuria and improve glycemic control aligns with a patient-centered approach to renal care.
In optimizing kidney protection, SGLT2 inhibitors exemplify the integration of evidence-based medicine into holistic care strategies. By targeting metabolic and hemodynamic pathways, they provide multifaceted benefits, including cardiovascular risk reduction. This comprehensive approach enables healthcare providers to improve outcomes in CKD patients while addressing interconnected health challenges.
Therefore, get an overall knowledge of Holistic CRM Care : Optimizing Kidney Protection with SLGT2-inhibitor. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions
See More Webinars @ Hidoc Webinars
1.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
2.
More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.
3.
What Role Should Genomic Classifier Testing Play in Prostate Cancer?
4.
A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma
5.
Squeezing through tiny blood vessels may trigger melanoma cells to spread
1.
The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies
2.
Everything You Need to Know About Leiomyomas: A Comprehensive Guide
3.
The Importance of Corrected Calcium Levels in Managing Health Conditions
4.
How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies
5.
Cowden Syndrome and Cancer: Understanding the Risk Factors
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
3.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation